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Abstract
Due to the ever-increasing rise of antimicrobial resistant (AMR) bacteria, the development of alternative antimicrobial agents 
is a global priority. The antimicrobial activity of ionic gold was explored against four Pseudomonas aeruginosa strains with 
different AMR profiles in order to determine the antimicrobial activity of ionic gold and elucidate the mechanisms of action. 
Disc diffusion assays (zone of inhibition: ZoI) coupled with minimum inhibitory/bactericidal concentrations (MIC/MBC) 
were conducted to determine the antimicrobial efficacy of ionic gold. Scanning electron microscopy (SEM) was used to 
visualise morphological changes to the bacterial cell ultrastructure. Strains with increased AMR were slower to grow which 
is likely a fitness cost due to the enhanced AMR activity. Although greater concentrations of ionic gold were required to 
promote antimicrobial activity, ionic gold demonstrated similar antimicrobial values against all strains tested. Lowry assay 
results indicated that protein leakage was apparent following incubation with ionic gold, whilst SEM revealed cellular ultra-
structure damage. This study suggests that the application of ionic gold as an alternative antimicrobial is promising, particu-
larly against AMR P. aeruginosa. The antimicrobial activity of ionic gold against P. aeruginosa could potentially be utilised 
as an alternative therapeutic option in wound management, an approach that could benefit healthcare systems worldwide.
Keywords Ionic gold · Metals · Resistance · Pseudomonas aeruginosa · Antimicrobials · Mechanism of action
Introduction
The emergence of antimicrobial resistance (AMR) is a major 
global issue, due to the persistent overuse of antimicrobi-
als, such as antibiotics in medicine and agriculture (Blair 
et al. 2015; Slate et al. 2019). Antimicrobial resistance 
can be defined as the ability of a microorganism to resist 
growth inhibition (and/or death) exerted by an antimicrobial, 
beyond the normal susceptibility of the microbial species 
(Verraes et al. 2013). In parallel to an increase in patient 
morbidity and mortality, AMR has placed a huge financial 
burden on healthcare services (Lowy 2003; Bassetti et al. 
2013; Breathnach 2013). The number of deaths caused by 
multidrug-resistant (MDR) bacteria worldwide is estimated 
to be approximately 700,000 deaths per annum (Tillotson 
and Zinner 2017). Furthermore, it is estimated that by 2050, 
mortality rates due to AMR infections will exceed 10 million 
people per year; superseding cancer as the leading cause 
of mortality worldwide (O’Neill 2018). The lack of effec-
tive therapies to combat AMR infections has resulted in an 
urgent need to develop alternative antimicrobial therapies 
(Ventola 2015).
Pseudomonas aeruginosa is a Gram-negative,  rod-
shaped, facultative anaerobic bacterium (Wilson and Dowl-
ing 1998). Owing to its remarkable metabolic versatility, 
it is able to assimilate a wide range of compounds, allow-
ing survival and proliferation in low nutrient and anaerobic 
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environments (Arai 2011; Wu et al. 2015). This versatility 
facilitates pathogenesis as it enables the bacteria to adapt to 
different microenvironments. This bacterium is an opportun-
istic pathogen, often causing infections in burns and immu-
nocompromised patients; it is the most prevalent organism 
isolated in cystic fibrosis patients (Fichtenbaum et al. 1994; 
Lyczak et al. 2000; Hart and Winstanley 2002; Turner et al. 
2014; Winstanley et al. 2016). Pseudomonas aeruginosa is 
a major cause of nosocomial infections and it is a major con-
tributor of chronic wound infections (Karaky et al., 2020). In 
addition, P. aeruginosa biofilms are particularly problematic 
due to the development of persister cells which can render 
traditional antibiotic therapies ineffective (Mulcahy et al. 
2014). For example, chronic wounds in diabetics patients 
are notoriously difficult to treat, due to the overwhelming 
presence of drug-tolerant persister cells (Dowd et al. 2011).
The use of metals in medical applications is an ancient 
practice (Lemire et al. 2013). Today, metals used in modern 
medicine as therapeutic agents include chemotherapy drugs, 
anti-arthritis drugs and antimicrobial agents (Mcquitty 
2014). Different metals and their metallic states (e.g. solid, 
metal ions/oxides, nanoparticles) have different antimicro-
bial efficacies. Due to the non-specificity of metals and their 
ability to target multiple bacterial sites simultaneously, the 
acquisition of antimicrobial resistance is deemed low (Zhou 
et al. 2012; Lemire et al. 2013; Southam et al. 2017). Multi-
ple applications have been described for gold nanoparticles, 
such as image detection and a carrier to transport drugs into 
cells (Yeh et al. 2012). Furthermore, ionic gold has previ-
ously demonstrated antimicrobial activity in both  Au1+ and 
 Au3+ variants (Shareena Dasari et al. 2015; Vaidya et al. 
2017).
The aim of this study was to determine the antimicrobial 
activity of ionic gold against a range of P. aeruginosa type 
strains and clinical isolates with different antibiotic resistant 




The bacterial strains utilised in this study included Pseu-
domonas aeruginosa (PAO1), P. aeruginosa (ATCC 9027) 
and two clinical P. aeruginosa isolates recovered from 
Manchester Royal Infirmary (MRI), (Manchester, UK) and 
Bolton Royal Hospital (RBH), (Bolton, UK). The strains 
were cultured using Tryptone Soya Agar (TSA) and Tryp-
tone Soya Broth (TSB) (Oxoid, UK), which were prepared 
in accordance with the manufacturer’s instructions. The 
bacterial strains were streaked onto TSA and incubated at 
37 ºC for 18 h. A single colony was transferred to 10 mL 
of TSB and incubated at 37 °C for 18 h in an orbital shaker 
(200 rpm) (GIO gyratory shaker, USA).
Antibiotics and ionic gold
Characterization of the antimicrobial activity of ionic gold 
was performed with the Gold Standard for AAS (atomic 
absorption spectroscopy) (Sigma-Aldrich, UK), which 
comprises of gold, dissolved in a 5% (v/v) HCl solution, 
with trace amounts of  HNO3 present, at a concentration of 
1000 μg  mL−1. The presence of nitric acid acts as a power-
ful oxidising agent to form  Au3+ ions, whilst the presence 
of HCl provides chloride ions which promote the formation 
of chloroaurate anions  (AuCl4−), this process is one of the 
most commonly employed methods in which gold is dis-
solved and the leaching reagent (the combination of HCl and 
 HNO3) is known as aqua regia (Rao et al. 2020; Bae et al. 
2020). The antibiotics included in this study were 5 µg cip-
rofloxacin, 30 µg ceftazidime and 30 µg gentamicin (Sigma-
Aldrich, UK) for diffusion assays. Whilst, solutions of these 
antibiotics were prepared at a maximum concentration of 
2048 μg  mL−1 in sterile distilled water, except ciprofloxacin, 
which was dissolved in 2% (v / v) acetic acid for minimum 
inhibitory/bactericidal concentration (MIC/MBC) assays. 
The antibiotics were stored at 4 °C prior to use.
Growth curves
Growth curves were prepared in 96-well, flat-bottomed cul-
ture plates (Sarstedt, USA), 200 µL of the starting inoculum 
was added, resulting in a starting culture of 0.05  OD600 nm in 
each well, which equated to ca. 0.5 ×  108 CFU  mL−1. Growth 
curve data (i.e. absorbance values) was recorded using a 
SPECTROstar Nano multiplate reader (UK), into which, the 
plate was inserted and maintained at 37 ºC with agitation 
at 120 rpm. Measurements were recorded automatically by 
determining the absorbance of each sample  (OD600 nm) every 
10 min for 22 h. For each strain, triplicate growth curves 
were performed (n = 3).
Antimicrobial susceptibility
Antimicrobial diffusion assays
Pseudomonas aeruginosa cultures were inoculated into TSB 
and incubated at 37 °C overnight with constant shaking 
(200 rpm). The cultures were diluted to an optical density 
 (OD600 nm) of 0.025. One hundred microliters of the bacte-
rial culture were pipetted onto TSA and spread across the 
agar. A commercial antibiotic disc ring device was placed 
onto the pre-inoculated agar (MAST, UK; M26/NCE) which 
was dried for 1 h and incubated overnight at 37 °C. After 
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incubation, the diameter of each zone of inhibition (ZoI) was 
measured using electronic callipers (n = 3). The commercial 
M26/NCE disk contained the following antibiotics, 25 µg 
ampicillin, 50 µg chloramphenicol, 100 µg colistin Sulphate, 
30 µg kanamycin, 30 µg nalidixic acid, 50 µg nitrofurantoin, 
25 µg streptomycin and 100 µg tetracycline.
For the determination of the antimicrobial efficacy of the 
specific antibiotics against P. aeruginosa, the method was 
carried out as above except that 10 μL of 5 µg ciprofloxacin, 
30 µg ceftazidime and 30 µg entamicin (Sigma-Aldrich, UK) 
and the ionic gold were added to sterile, antibiotic-free 6 mm 
diffusion discs (Sigma-Aldrich, UK) which were deposited 
onto the surface of the agar. As 5% HCl was used as the 
diluent for the gold, this was also tested and the observed 
ZoI was subtracted from the final ionic gold ZoI value. The 
inoculated plates were incubated and measured as above 
(n = 3). The antibiotics were dissolved in sterile distilled 
water except for ciprofloxacin, which was dissolved in 2% 
(v/v) acetic acid.
Minimum inhibitory concentration (MIC)
To determine the minimum inhibitory concentration (MIC), 
the strains were inoculated in TSB medium for 18 h at 
37 °C. Bacterial cultures were centrifuged at 1721 × g, and 
the supernatant was removed, P. aeruginosa was normal-
ised to an optical density of 0.05 at OD 600 nm in double-
strength TSB, which equated to ca. 0.5 ×  108 CFU  mL−1. 
The antibiotics were dissolved to a final concentration of 
2048 μg  mL−1. In a 96 well plate, the outer wells were filled 
with 200 µL sterile TSB. In the second column of wells, 
200 µL of the antimicrobials at the maximum concentra-
tion and 100 μL of sterile distilled water was added to the 
sequential columns. A twofold dilution was carried out, 
100 μL of the solution was transferred into the next column 
(column three); this process was repeated until column ten, 
where 100 µL of the solution was discarded ensuring all 
wells had a 100 µL total volume. Normalised P. aeruginosa  
solutions were combined with 0.15% triphenyl blue chlo-
ride (TBC) (this was included as a metabolic activity indi-
cator). Aliquots of 100 μL of the bacterial suspension was 
then added to each well, giving a final volume of 200 μL. 
To avoid evaporation, the plate was closed and sealed with 
 Parafilm®. The outer wells that contained sterile TSB served 
as the negative control. Column eleven contained P. aerugi-
nosa but no antimicrobial (positive control). The plates were 
incubated at 37 °C for 18 h without agitation. This study was 
also conducted with the solvents the antimicrobials were 
dissolved in to ensure that the antimicrobial activity was 
not produced solely by the solvents. Following incubation, 
the MIC of the antimicrobial was defined as the minimum 
concentration that inhibited visible growth in that well, 
compared with the positive and negative controls utilised 
in this study (n = 3).
Minimum bactericidal concentration (MBC)
To determine the minimum bactericidal concentration 
(MBC), 25 μL of solution was taken from the last well 
(and the two concentrations above and below this) that 
demonstrated growth inhibition. The culture was spread 
across TSA and dried at room temperature for 1 h whilst 
maintaining aseptic conditions, before being incubated at 
37 °C for 18 h without agitation. Following incubation, the 
lowest concentration that exhibited no growth was consid-
ered the MBC (n = 3).
Determination of extracellular proteins
To quantify the concentration of proteins released into the 
extracellular media, 100 mL of TSB was inoculated with 
P. aeruginosa and incubated at 37 °C for 18 h with con-
stant agitation (200 rpm). The bacterial suspensions were 
centrifuged at 1721 × g for 7 min and replaced with PBS, 
this washing step was repeated twice before cultures were 
normalised to 1.00  OD600 nm. An aliquot of 2 mL of each 
sample was taken and added to the predetermined MIC 
concentration of the antimicrobial. A 2 mL aliquot was 
simultaneously treated with cetyltrimethylammonium bro-
mide (CTAB) at the predetermined MIC concentration, 
which was established as the positive control. A third 
aliquot of the same volume, but untreated, was used as 
a negative control. The samples were incubated for 2 h 
at 37 °C and centrifuged at 10,625 × g for 15 min. The 
supernatant was collected and a Lowry assay for protein 
determination was performed (Lowry et al. 1951; Olson 
and Markwell 2007).
Lowry method
The supernatant was diluted into 1:50, 1:200 and 
1:1000 dilutions using sterile PBS. Aliquots of 5 mL of 
extemporaneous Lowry reagent (50 mL of alkaline rea-
gent + 0.5 mL of copper reagent (Lowry et al. 1951) were 
added, vortexed for 10 s and incubated at room tempera-
ture for 10 min. Folin–Cicocalteau reagent (0.5 mL diluted 
in the same volume of deionised water) was added to the 
mixture and was left to stand for 30 min. The absorb-
ance of the sample was measured in a spectrophotometer 
(Jenway, UK) at  OD660 nm. The results were expressed as 
percentage protein release. For the quantification of the 
protein (mg), a calibration curve was performed utilis-
ing increasing known concentrations of bovine serum 
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albumin (BSA) at 0 μg  mL−1, 0.5 μg  mL−1, 2.5 μg  mL−1, 
5 μg  mL−1, 10 μg  mL−1, 15 μg  mL−1 and 20 μg  mL−1.
Scanning electron microscopy (SEM)
All P. aeruginosa strains were inoculated in 10 mL TSB 
and incubated overnight at 37 °C with constant shaking 
(200 rpm). After incubation, the optical density of the bac-
terial suspension was adjusted to 0.5  (OD600 nm) and treated 
with ionic gold at the predetermined MIC concentration, 
for 2 h and 18 h. An untreated aliquot was used as a neg-
ative control. The cultures were centrifuged for 7 min at 
1721 × g and washed with PBS. Aliquots of 25 μL of culture 
were placed on sterile stainless steel (316L) (1 cm × 1 cm) 
and dried for 1 h at room temperature. The samples were 
immersed in 4% glutaraldehyde (Agar Scientific, UK) at 
4 ºC for 18 h. The samples were dehydrated by sequential 
submersion in an ethanol gradient of increasing concentra-
tions (10%, 30%, 50%, 70%, 90% and absolute ethanol). The 
dehydrated samples were placed onto carbon tabs (Agar Sci-
entific, UK). Samples were dried by desiccation over 24 h 
and were sputter coated with gold (Polaron, UK) for 30 s 
(parameters: power 5 mA, 30 s, 800 V, vacuum 0.09 mbar, 
argon gas) prior to imaging using a JEOL JSM 5600LV 
scanning electron microscope.
Statistical analysis
All experiments were performed in triplicate (n = 3). The 
error bars shown in the graphs correspond to the standard 
error of the mean. Statistical analysis of the data was carried 
out using Prism 8 (Version 8.4.3), following Shapiro–Wilk 
normality analysis, significant differences were determined 
at p < 0.05 using two-way ANOVAs coupled with Tukey’s 
tests for post hoc analysis. Asterisks denote significance, 
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and ****p ≤ 0.0001.
Results
Bacterial growth curves
Growth curves were conducted for all the P. aeruginosa 
strains utilised in this study (Fig. 1). The growth curves 
obtained demonstrated a traditional four stage growth curve 
with lag, log (exponential), stationery and death phases 
observed. At 4 h, the P. aeruginosa strains began to display 
different growth patterns; P. aeruginosa strain ATCC 9027 
entered the exponential phase well in advance of the other 
strains. P. aeruginosa strain RBH demonstrated the shortest 
exponential phase producing the lowest  OD600 nm (0.68 after 
11.17 h incubation). The strain that generated the highest 
 OD600 nm and therefore produced the highest biomass was 
P. aeruginosa strain PAO1 (1.85 after 13.67 h incubation), 
followed by P. aeruginosa strain MRI (1.64 after 14.83 h 
incubation), then P. aeruginosa strain ATCC 9027 (1.59 
after 15.83 h incubation).
The Td (where Td is the time required for the population 
to double the number of cells) and highest μ (growth rate) 
of each strain was calculated (Table 1). P. aeruginosa strain 
ATCC 9027 doubled in the least amount of time (Td: 2.1 h) 
producing the highest growth rate (μ: 0.33  h−1). In contrast, 
P. aeruginosa strain RBH was the slowest dividing strain 
in this study, producing a Td of 3.9 h and the lowest growth 
rate (μ: 0.18  h−1).
Antibiotic resistance profiles
The antibiotic resistance profiles of the P. aeruginosa strains 
were determined (Fig. 2). Bacterial isolates were defined as 
antibiotic resistant (AMR) if they were resistant to multiple 
antibiotics. The least susceptible P. aeruginosa strains were 
PAO1 and RBH, both of which demonstrated resistance to 
four of the eight antibiotics tested. Pseudomonas aeruginosa 
strain PAO1 exhibited no sensitivity to ampicillin, chloram-
phenicol, nalidixic acid and nitrofurantoin. P. aeruginosa 
strain RBH showed no sensitivity to chloramphenicol, 
Fig. 1  Growth kinetics of the four P. aeruginosa strains,  OD600  nm 
(conditions: TSB, 37  °C, 120  rpm agitation) was recorded every 
10 min for 24 h (n = 3)
Table 1  Kinetic parameters obtained from growth curves: doubling 
time (Td) and specific growth rate (μ) (n = 3).
P. aeruginosa strain Td (h) µ (h −1)
PAO1 2.9 (± 0.3) 0.24 (± 0.02)
ATCC 9027 2.1 (± 0.1) 0.33 (± 0.02)
MRI 2.7 (± 0.02) 0.26 (± 0.002)
RBH 3.9 (± 0.07) 0.18 (± 0.003)
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kanamycin, nitrofurantoin and nalidixic acid. Pseudomonas 
aeruginosa strains ATCC 9027 and MRI were the most sus-
ceptible, with growth inhibition observed against all of the 
antibiotics tested. The largest zone of inhibition observed 
(25.1 mm) was produced using tetracycline against P. aer-
uginosa strains ATCC 9027.
Antimicrobial activity of ionic gold and target 
antibiotics
The antimicrobial activity of the ionic gold was character-
ised using zone of inhibition assays and minimum inhibi-
tory/bactericidal concentrations. The antibiotics (ciprofloxa-
cin, ceftazidime and gentamicin) which are regularly used 
to treat P. aeruginosa infections were used as appropriate 
comparisons. Ionic gold demonstrated antimicrobial activ-
ity against all four P. aeruginosa strains (Fig. 3). Ionic gold 
exhibited the least antimicrobial effect against P. aerugi-
nosa strain RBH, producing a ZoI of 13.7 mm and the great-
est effect against P. aeruginosa ATCC 9027 (28.89 mm). 
The inhibition of the bacterial growth in the presence of 
ionic gold were similar between the P. aeruginosa strains 
(13.69 mm – 26.89 mm). However, although the ionic gold 
demonstrated antimicrobial efficacy, when compared with 
the antibiotics (8.88 mm – 42.33 mm), the ionic gold inhibi-
tion values were significantly lower (p < 0.001). Ciprofloxa-
cin produced the largest ZoI against P. aeruginosa strain 
MRI (42.3 mm).
The MICs of ionic gold was consistent against the P. 
aeruginosa strains (26.00  µg   mL−1 –  31.25  µg   mL−1) 
(Fig.  4). The antibiotics in this study produced sig-
nificantly lower MIC values than the ionic gold 
(0.71 μg  mL−1 – 25.60 μg  mL−1) (p < 0.01), except for genta-
mycin against P. aeruginosa strain ATCC 9027 which exhib-
ited a MIC of 25.60 µg  mL−1. All three target antibiotics 
(gentamycin, ciprofloxacin and ceftazidime) were effective 
at inhibiting P. aeruginosa growth and ciprofloxacin was 
the most effective producing MIC values in the range of 
0.8 µg  mL−1 – 2.7 µg  mL−1.
Fig. 2  Pseudomonas aeruginosa  antimicrobial sensitivity profiles 
determined by zone of inhibition measurements against a range 
of commonly prescribed antibiotics (n = 3). Asterisks denote signifi-
cance, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and ****p ≤ 0.0001
Fig. 3  Zones of inhibition of gentamycin, ciprofloxacin, ceftazidime 
and ionic gold against P. aeruginosa strains after 18 h incubation at 
37  °C (n = 3). Asterisks denote significance, *p ≤ 0.05, **p ≤ 0.01, 
***p ≤ 0.001 and ****p ≤ 0.0001
Fig. 4  Minimal inhibitory concentrations (MIC) of gentamycin, cip-
rofloxacin, ceftazidime and ionic gold against P. aeruginosa strains 
after 18 h incubation (conditions: TSB, 37 °C, static) (n = 3). Aster-
isks denote significance, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and 
****p ≤ 0.0001
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Minimum bactericidal concentration (MBC)
The MBC of ionic gold and gentamycin, ciprofloxacin and 
ceftazidime was determined (Fig. 5). A higher concentration 
of ionic gold was required to eradicate the P. aeruginosa 
strains producing MBC values ranging from 31.3 µg  mL−1 
to 34.7 µg  mL−1. The required MBC of gentamycin, cip-
rofloxacin and ceftazidime was lower than ionic gold 
except for gentamycin against P. aeruginosa strain PAO1 
(96.7 µg  mL−1). The most effective antimicrobial in this 
study was ciprofloxacin, producing the lowest MBC range, 
2.7 µg  mL−1 – 9.6 µg  mL−1. No bactericidal activity was 
observed by ceftazidime against three of the four P. aerugi-
nosa strains, an MBC of 0.99 µg  mL−1 was observed against 
P. aeruginosa strain ATCC 9027, with growth observed at 
the maximum concentrations tested.
Effect of ionic gold on P. aeruginosa cellular 
ultrastructure
Protein release into the extracellular medium was measured 
using the Lowry assay. Protein release was determined after 
two separate incubation periods, 2 h and 18 h to determine 
both the short- and long-term exposure effects of the ionic 
gold against P. aeruginosa (Fig. 6). After short-term expo-
sure (2 h), only two (ATCC 9027 and MRI) of the four P. 
aeruginosa strains demonstrated protein leakage from the 
cytoplasm into the surrounding growth media. However, 
after 18 h incubation with ionic gold all four P. aeruginosa 
strains exhibited protein release with P. aeruginosa strain 
MRI demonstrating the greatest protein release after 18 h 
(17.5%). Interestingly, the greatest protein leakage (60.3%) 
was determined after 2 h incubation from P. aeruginosa 
strain ATCC 9027.
Scanning electron microscopy (SEM)
To verify the protein leakage assays, scanning electron 
microscopy (SEM) was conducted, so that the antimicrobial 
effect of ionic gold on the P. aeruginosa ultrastructure could 
be visualised (Fig. 7). The results demonstrated that after 2 h 
incubation with ionic gold the cellular ultrastructure of P. 
aeruginosa strain PAO1 was compromised, this was evident 
by the appurtenance of defects in the cell membrane which 
could indicate leakage of intercellular material (Fig. 7b). 
After 12 h incubation, cellular debris was evident, and the 
P. aeruginosa cell morphology had altered. The intact cells 
demonstrated small nodules which could be observed along 
the surface (Fig. 7c).
Discussion
Antimicrobial resistance (AMR) is an ever-exacerbating, 
global threat to human and animal health (Aslam et al. 
2018). Factors such as excessive overuse of antibiotics, 
poor sanitation/hygiene, increased international travel and 
the release of non-metabolised antibiotics (or their residues) 
into the environment through faeces/manure, can all contrib-
ute to AMR (Ventola 2015; Aslam et al. 2018; Slate et al. 
2018). Due to this, research into alternative antimicrobial 
therapies is of paramount importance.
The disc diffusion assays demonstrated that the ionic 
gold and ceftazidime exhibited similar antimicrobial effects 
against all the P. aeruginosa strains, whilst the antibiotics 
gentamicin and ciprofloxacin demonstrated more diverse 
zones of inhibition for the bacteria. Both the clinical strains 
demonstrated the greatest antimicrobial resistance. The 
Fig. 5  Minimal bactericidal concentrations (MBC) of gentamy-
cin, ciprofloxacin, ceftazidime and ionic gold against P. aerugi-
nosa strains after 18  h incubation (n = 3). Against P. aeruginosa 
strains PAO1, MRI and RBH, Ceftazidime demonstrated no bacte-
ricidal  activity. Asterisks denote significance, *p ≤ 0.05, **p ≤ 0.01, 
***p ≤ 0.001 and ****p ≤ 0.0001
Fig. 6  Percentage of protein released from the cytoplasm of P. aer-
uginosa due to the activity of ionic gold (n = 3)
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difference in the growth and antibiotic resistance profiles 
demonstrates the need for bacterial strains from relevant 
environments to also be used in studies alongside type 
strains. The results from this study demonstrated that the 
clinical P. aeruginosa strains produced the slowest growth 
rate. This could be related to their antimicrobial resistance 
profiles, as resistance mutations are known to infer signifi-
cant fitness costs (Melnyk et al. 2015).
The results for the MICs and MBCs of the ionic gold 
were consistent between the P. aeruginosa strains. The anti-
biotics in this study produced significantly lower MIC values 
than the ionic gold. However, in four cases, the MBCs of 
the ionic gold proved to have MBCs lower than some of 
the antibiotics. The antimicrobial efficacy of the ionic gold 
was not related to the antimicrobial resistance profiles of 
the bacteria, and the ionic gold demonstrated similar anti-
microbial values against all the strains tested, regardless of 
the assay used. Thus, unlike the antibiotics, the bactericidal 
activity of the ionic gold was effective against all the P. 
aeruginosa strains regardless of their antibiotic resistance 
profile. Although ionic gold demonstrated lower antimi-
crobial activity than commonly used antibiotics against P. 
aeruginosa, the multiple antimicrobial mechanisms which 
occur simultaneously, may result in less resistance genera-
tion (Lansdown 2002; Gold et al. 2018). This suggests that 
when antibiotic use is not viable due to resistance concerns, 
the use of an alternative antimicrobials such as ionic gold 
may be one alternative approach.
Gold is a rare, inert and non-essential heavy metal to bac-
teria (Srivastava et al. 2013; Wyatt et al. 2014). Ionic gold in 
the form of  Au+ and  Au3+ has known antimicrobial activity 
(Zhang et al. 2015). Few studies have demonstrated the anti-
microbial efficacy of ionic gold; however, a plethora of stud-
ies have demonstrated antimicrobial activity of gold nano-
particles and gold containing compounds (such as auranofin) 
(Li et al. 2014; Thangamani et al. 2016; Vaidya et al. 2017). 
In 2015, Dasari et al., demonstrated the antibacterial activity 
of ionic gold against four different bacteria, including one 
non-pathogenic bacterial species, Escherichia coli and three 
MDR bacterial species’: E. coli, Salmonella typhiurium 
and Staphylococcus aureus (Dasari et al. 2015). Both  Au+ 
and  Au3+ were highly toxic to all four bacteria, with  Au+ 
producing an  IC50 (half maximal inhibitory concentration) 
range of 0.35 µM – 0.49 µM, whilst  Au3+ produced an  IC50 
range of 0.27 µM – 0.52 µM (Dasari et al. 2015). In a recent 
study by Karaky et al (2020), ionic gold produced a MIC of 
26 µg  mL−1 and a MBC of 41.7 µg  mL−1 against two clinical 
isolates of P. aeruginosa (Karaky et al. 2020).
Despite the known antimicrobial activity of ionic gold, 
the mechanism of action is yet to be fully elucidated. Like 
other metal ions, the antimicrobial activity is hypothesised 
to involve multiple mechanisms (Lemire et al. 2013; Wang 
et al. 2016). Such antimicrobial mechanisms are thought to 
Fig. 7  Scanning electron microscopy  (SEM) of P. aeruginosa (a) 
PAO1 control (b) ionic gold treated for 2 h and (c) ionic gold treated 
for 18 h
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include the generation of reactive oxygen species (ROS) and 
the depletion of antioxidants. In addition, metal ions can 
bind to the thiol groups of proteins and enzymes leading to 
dysfunction (Feng et al. 2000; Lemire et al. 2013; Stiefel 
et al. 2015). These mechanisms can damage cellular mem-
branes, disrupt electron transport and interfere with nutri-
ent acquisition, ultimately resulting in cell lysis and death 
(Sondi and Salopek-Sondi 2004; Hobman and Crossman 
2015). Furthermore, metal ions can also intercalate with 
the phosphorous elements of bacterial DNA, resulting in 
an impaired ability to replicate (Kim et al. 2007). Although 
resistance to metal ions has been observed previously 
(Lemire et al. 2013), it is less likely to be effective at com-
pletely inhibiting the antimicrobial activity when compared 
with traditional antibiotics, due to the multiple mechanisms 
of cellular disruption involved, simultaneously. Throughout 
this study, P. aeruginosa protein leakage into the extracellu-
lar media due to the presence of ionic gold was demonstrated 
using a protein quantification assay (Lowry assay) and SEM 
visualisation, and it was evident that all four P. aeruginosa 
strains demonstrated cellular leakage and damage. This sug-
gests that damage to the cellular ultrastructure was in part 
responsible for the antimicrobial activity of ionic gold.
For ionic gold to be applied as a topical agent or as part 
of a wound dressing its cytotoxicity towards relevant mam-
malian cells must be considered. The cytotoxicity of gold 
ions and gold nanoparticles is poorly understood with stud-
ies suggesting controversial results throughout the literature 
(Alkilany and Murphy 2010; Barbasz and Oćwieja 2016; 
Falagan-Lotsch et al. 2016; Gunduz et al. 2017). Ionic gold 
is a powerful inhibitor of macrophages and polymorphonu-
clear leucocytes. However, most reports focus on the release 
of ionic gold from prototype implants and cellular accumu-
lation (Hostynek 1997; Danscher 2002). However, Barbasz 
et al., (2016) determined that gold ions had no significant 
antimicrobial activity on either a human monocytic (U-937) 
or a human promyelocytic leukaemia cell line, demonstrating 
a 9% and 12% reduction in cell survival, respectively, when 
compared with the control (Barbasz and Oćwieja 2016). 
The presence of gold ions although deemed non-toxic, has 
been shown to enhance nitric oxide concentrations fivefold, 
indicating an inflammatory response (Barbasz and Oćwieja 
2016). To progress ionic gold as a topical ointment, wound 
dressing or implant coating further research is required in 
determining both the mode of antimicrobial action of ionic 
gold and its effect on mammalian cytotoxicity.
Conclusions
Throughout this study, the antimicrobial activity of ionic 
gold was evaluated against four P. aeruginosa strains and 
were compared against commonly prescribed antibiotics. 
Both the clinical strains demonstrated the greatest anti-
microbial resistance profiles. The difference in the growth 
and antibiotic resistance profiles demonstrates the need 
for bacterial strains from relevant environments to also be 
used in studies alongside type strains. The clinical bacterial 
strains of P. aeruginosa demonstrated they were the slowest 
at dividing and this could be related to their antimicrobial 
resistance profiles. Throughout the MBC assays, ionic gold 
demonstrated good bactericidal activity against the P. aer-
uginosa strains. The antimicrobial efficacy of the ionic gold 
was not related to the antimicrobial resistance profiles of the 
bacteria, and the ionic gold demonstrated similar antimicro-
bial values for all the strains tested, regardless of the assay 
used. Although ionic gold demonstrated lower antimicrobial 
activity against P. aeruginosa, when compared with the anti-
biotics which are commonly utilised, the multiple antimicro-
bial mechanisms which occur simultaneously, may result in 
less resistance generation. The results from this study indi-
cated that protein leakage was apparent, upon incubation 
with ionic gold, demonstrating damage to the P. aeruginosa 
cell ultrastructure. Therefore, the utilisation of ionic gold as 
an antimicrobial topical agent, or as part of a wound dressing 
or implant coating may be potential avenues to be explored 
to reduce excessive antibiotic use.
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